Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high growth high margin stocks to buy now. On January 28, Barclays began coverage of Vertex Pharmaceuticals Incorporated ...

WASHINGTON-When Health and Human Services Secretary Robert F. Kennedy Jr. summoned infant-formula executives to Washington last spring, he arrived with a list of questions about seed oils, heavy ...

If you're in the market for new headphones, you're in luck! Beats is having a sale on Amazon for over 50% off. Plus, check ...

The Camfather was 104 ...

Unilever and Google Cloud today announced a five-year partnership to accelerate Unilever's business transformation through its use of Google Cloud's advanced AI, data, platform and next-generation ...

Vertex Pharmaceuticals forecast 2026 revenue largely in line with analysts estimates on Thursday, as the drugmaker bets on growth for its cystic fibrosis treatments as well as contributions from newer ...

Alphabet's TPU program sets an internal cost floor independent of Nvidia’s pricing power. Click here to read an analysis of ...

Q4 2025 Earnings Call February 18, 2026 9:00 AM ESTCompany ParticipantsRoushan Ahmadi-Zenooz - Senior Vice President of ...

In mid-January 2026, Bernstein upgraded Vertex Pharmaceuticals to Outperform and UBS initiated coverage with a Buy rating, both citing confidence in the company’s core cystic fibrosis business and ...

If you're looking for a way to make your next get-together with family and friends more fun, engaging and even educational, ...